| SIM0017-5MG
| InVivoSIM anti-human NGF (Tanezumab Biosimilar)
| 5 mg
| BioXCell
| NGF neutralization
, , ELISA
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| SIM0028-25MG
| InVivoSIM anti-human RANKL (CD254) (Denosumab Biosimilar)
| 25 mg
| BioXCell
| Functional assays, Flow Cytometry,
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| SIM0014-25MG
| InVivoSIM anti-human IL-6R (Tocilizumab Biosimilar)
| 25 mg
| BioXCell
| Functional assays, ELISA
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| SIM0026-25MG
| InVivoSIM anti-human Claudin 18.2 (Zolbetuximab Biosimilar)
| 25 mg
| BioXCell
| Functional assays, ,
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| SIM0008-25MG
| InVivoSIM anti-human CD20 (Rituximab Biosimilar)
| 25 mg
| BioXCell
| Flow Cytometry
, , ELISA
, , Western Blot
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| CP132-1MG
| RecombiMAb anti-mouse VEGFR-2
| 1 mg
| BioXCell
| in vivo blocking of VEGF/VEGFR-2 signaling*, in vi
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0007-100MG
| InVivoSIM anti-human VEGF (Bevacizumab Biosimilar)
| 100 mg
| BioXCell
| VEGF neutralization
, , Flow Cytometry
, , ELISA
,
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| RT0269-1MG
| ReadyTag anti-DDDDK
| 1 mg
| BioXCell
| Western blot, Immunoprecipitation, Immunofluoresce
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| RT0266-1MG
| ReadyTag anti-6-His
| 1 mg
| BioXCell
| Western blot, Immunoprecipitation, Immunofluoresce
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| SIM0010-1MG
| InVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar)
| 1 mg
| BioXCell
| Blocking of PD-1/PD-L signaling, Functional assays
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| CP149-100MG
| RecombiMAb human IgG1 (LALA-PG) isotype control, anti-hen egg lysozyme
| 100 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| CP154-100MG
| RecombiMAb anti-mouse PD-L1 (B7-H1) (LALA-PG)
| 100 mg
| BioXCell
| in vivo PD-L1 blockade*, Immunofluorescence*, Immu
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| CP047-25MG
| RecombiMAb mouse IgG1 (D265A) isotype control, anti-hen egg lysozyme
| 25 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| SIM0016-100MG
| InVivoSIM anti-human IgE (Omalizumab Biosimilar)
| 100 mg
| BioXCell
| IgE neutralization
, , Flow cytometry
, , ELISA
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| CP173-1MG
| RecombiMAb human IgG1 (D265A) isotype control, anti-hen egg lysozyme
| 1 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| SIM0002-50MG
| InVivoSIM anti-human EGFR (Cetuximab Biosimilar)
| 50 mg
| BioXCell
| EGFR blockade, ELISA, Flow Cytometry
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| CP034-1MG
| RecombiMAb anti-mouse CD40L (CD154) (LALA-PG)
| 1 mg
| BioXCell
| in vivo blocking of CD40/CD40L signaling*, in vitr
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| CP131-25MG
| RecombiMAb anti-mouse CSF1R (CD115)
| 25 mg
| BioXCell
| in vivo macrophage depletion*, in vitro CSF1R neut
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| CP132-5MG
| RecombiMAb anti-mouse VEGFR-2
| 5 mg
| BioXCell
| in vivo blocking of VEGF/VEGFR-2 signaling*, in vi
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0013-1MG
| InVivoSIM anti-human IL-17A (Secukinumab Biosimilar)
| 1 mg
| BioXCell
| Functional assays, ELISA, Immunofluoresence, Immun
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| CP047-100MG
| RecombiMAb mouse IgG1 (D265A) isotype control, anti-hen egg lysozyme
| 100 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| SIM0002-25MG
| InVivoSIM anti-human EGFR (Cetuximab Biosimilar)
| 25 mg
| BioXCell
| EGFR blockade, ELISA, Flow Cytometry
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| CP147-1MG
| RecombiMAb human IgG4 (S228P) isotype control, anti-hen egg lysozyme
| 1 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| CP133-50MG
| RecombiMAb anti-mouse CD40
| 50 mg
| BioXCell
| in vivo CD40 activation*, in vitro B cell stimulat
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0007-50MG
| InVivoSIM anti-human VEGF (Bevacizumab Biosimilar)
| 50 mg
| BioXCell
| VEGF neutralization
, , Flow Cytometry
, , ELISA
,
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| SIM0010-100MG
| InVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar)
| 100 mg
| BioXCell
| Blocking of PD-1/PD-L signaling, Functional assays
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| RT0264-5MG
| ReadyTag anti-GST
| 5 mg
| BioXCell
| Western blot
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| CP130-25MG
| RecombiMAb anti-mouse CD71 (TfR1)
| 25 mg
| BioXCell
| in vivo depletion of CD71+ cells*, *Reported for t
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0025-50MG
| InVivoSIM anti-human IL-23 (p19) (Guselkumab Biosimilar)
| 50 mg
| BioXCell
| IL-23p19 neutralization, Functional assays, ELISA,
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| CP160-1MG
| RecombiMAb mouse IgG2a isotype control, unknown specificity
| 1 mg
| BioXCell
| in vivo LAG-3 neutralization*, in vitro LAG-3 neut
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| CP159-25MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*
, in vitr
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| SIM0002-5MG
| InVivoSIM anti-human EGFR (Cetuximab Biosimilar)
| 5 mg
| BioXCell
| EGFR blockade, ELISA, Flow Cytometry
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| SIM0025-25MG
| InVivoSIM anti-human IL-23 (p19) (Guselkumab Biosimilar)
| 25 mg
| BioXCell
| IL-23p19 neutralization, Functional assays, ELISA,
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| CP004-1MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 1 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, in vitro
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0014-5MG
| InVivoSIM anti-human IL-6R (Tocilizumab Biosimilar)
| 5 mg
| BioXCell
| Functional assays, ELISA
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| SIM0020-100MG
| InVivoSIM anti-human IL-12 p40 (Ustekinumab Biosimilar)
| 100 mg
| BioXCell
| Functional assays,
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| CP005-1MG
| RecombiMAb anti-mouse PD-1 (CD279) (D265A)
| 1 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*
, in vitr
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| CP048-25MG
| RecombiMAb mouse IgG2a (LALA-PG) isotype control, anti-hen egg lysozyme
| 25 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| IP0070-50ML
| InVivoPure pH 7.0 Dilution Buffer
| 50 ml
| BioXCell
|
|
|
|
| Solicitar Precio
| Solicitar
|
| CP129-5MG
| RecombiMAb anti-mouse Ly6G
| 5 mg
| BioXCell
| in vivo neutrophil depletion*, in vivo MDSC deplet
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| CP153-5MG
| RecombiMAb anti-mouse PD-1 (CD279) (LALA-PG)
| 5 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| RT0266-25MG
| ReadyTag anti-6-His
| 25 mg
| BioXCell
| Western blot, Immunoprecipitation, Immunofluoresce
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| CP161-100MG
| RecombiMAb human IgG1 (LALA-PG) isotype control, anti-respiratory syncytial virus
| 100 mg
| BioXCell
|
|
| Human
| Virus
| Solicitar Precio
| Solicitar
|
| CP026-1MG
| RecombiMAb anti-mouse CD16/CD32 (LALA-PG)
| 1 mg
| BioXCell
| in vitro Fc receptor blocking*, in vivo Fc recepto
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0366-25MG
| InVivoPlus mouse IgG2c isotype control, anti-dengue virus
| 25 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| SIM0023-5MG
| InVivoSIM anti-human IL-4R? (CD124) (Dupilumab Biosimilar)
| 5 mg
| BioXCell
| Functional assays,
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| CP131-5MG
| RecombiMAb anti-mouse CSF1R (CD115)
| 5 mg
| BioXCell
| in vivo macrophage depletion*, in vitro CSF1R neut
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| RT0267-25MG
| ReadyTag anti-OVA
| 25 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| RT0268-25MG
| ReadyTag anti-HA
| 25 mg
| BioXCell
| ELISA, Western blot, Immunoprecipitation, Immunofl
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| CP135-50MG
| RecombiMAb anti-mouse Ly6G/Ly6C (Gr-1)
| 50 mg
| BioXCell
| in vivo depletion of Gr-1+ myeloid cells*, Flow cy
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|